8FG1

Human diaphanous inhibitory domain bound to diaphanous autoregulatory domain


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the least restraint violations 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Disruption of the productive encounter complex results in dysregulation of DIAPH1 activity.

Theophall, G.G.Ramirez, L.M.S.Premo, A.Reverdatto, S.Manigrasso, M.B.Yepuri, G.Burz, D.S.Ramasamy, R.Schmidt, A.M.Shekhtman, A.

(2023) J Biol Chem 299: 105342-105342

  • DOI: https://doi.org/10.1016/j.jbc.2023.105342
  • Primary Citation of Related Structures:  
    8FG1

  • PubMed Abstract: 

    The diaphanous-related formin, Diaphanous 1 (DIAPH1), is required for the assembly of Filamentous (F)-actin structures. DIAPH1 is an intracellular effector of the receptor for advanced glycation end products (RAGE) and contributes to RAGE signaling and effects such as increased cell migration upon RAGE stimulation. Mutations in DIAPH1, including those in the basic "RRKR" motif of its autoregulatory domain, diaphanous autoinhibitory domain (DAD), are implicated in hearing loss, macrothrombocytopenia, and cardiovascular diseases. The solution structure of the complex between the N-terminal inhibitory domain, DID, and the C-terminal DAD, resolved by NMR spectroscopy shows only transient interactions between DID and the basic motif of DAD, resembling those found in encounter complexes. Cross-linking studies placed the RRKR motif into the negatively charged cavity of DID. Neutralizing the cavity resulted in a 5-fold decrease in the binding affinity and 4-fold decrease in the association rate constant of DAD for DID, indicating that the RRKR interactions with DID form a productive encounter complex. A DIAPH1 mutant containing a neutralized RRKR binding cavity shows excessive colocalization with actin and is unresponsive to RAGE stimulation. This is the first demonstration of a specific alteration of the surfaces responsible for productive encounter complexation with implications for human pathology.


  • Organizational Affiliation

    Department of Chemistry, State University of New York at Albany, Albany, New York, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Protein diaphanous homolog 1256Homo sapiensMutation(s): 0 
Gene Names: DIAPH1DIAP1
UniProt & NIH Common Fund Data Resources
Find proteins for O60610 (Homo sapiens)
Explore O60610 
Go to UniProtKB:  O60610
PHAROS:  O60610
GTEx:  ENSG00000131504 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO60610
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
Protein diaphanous homolog 129Homo sapiensMutation(s): 1 
Gene Names: DIAPH1DIAP1
UniProt & NIH Common Fund Data Resources
Find proteins for O60610 (Homo sapiens)
Explore O60610 
Go to UniProtKB:  O60610
PHAROS:  O60610
GTEx:  ENSG00000131504 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO60610
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the least restraint violations 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United States5R01GM085006
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease (NIH/NIDDK)United States1R01DK122456
National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)United States5P0HL146367

Revision History  (Full details and data files)

  • Version 1.0: 2023-10-25
    Type: Initial release
  • Version 1.1: 2023-11-15
    Changes: Database references